Palisade Capital Management LLC NJ cut its position in Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 742,289 shares of the company’s stock after selling 27,602 shares during the quarter. Palisade Capital Management LLC […]
Shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) have been assigned a consensus rating of “Hold” from the eight analysts that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year […]
Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) Director Mark S. Ordan sold 33,000 shares of Pediatrix Medical Group stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $13.26, for a total transaction of $437,580.00. Following the completion of the transaction, the director now directly […]
Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) Director Mark S. Ordan sold 33,000 shares of the firm’s stock in a transaction dated Thursday, May 25th. The stock was sold at an average price of $13.26, for a total transaction of $437,580.00. Following the completion of the sale, the director now owns 147,923 shares of […]
Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) Director Shirley A. Weis sold 17,993 shares of Pediatrix Medical Group stock in a transaction that occurred on Thursday, May 18th. The shares were sold at an average price of $13.55, for a total value of $243,805.15. Following the completion of the sale, the director now owns […]